Literature DB >> 30878534

Regional vulnerability and spreading of hyperphosphorylated tau in seeded mouse brain.

Jan R Detrez1, Hervé Maurin2, Kristof Van Kolen2, Roland Willems2, Julien Colombelli3, Benoit Lechat4, Bart Roucourt5, Fred Van Leuven6, Sarah Baatout7, Peter Larsen2, Rony Nuydens2, Jean-Pierre Timmermans8, Winnok H De Vos9.   

Abstract

We have exploited whole brain microscopy to map the progressive deposition of hyperphosphorylated tau in intact, cleared mouse brain. We found that the three-dimensional spreading pattern of hyperphosphorylated tau in the brain of an aging Tau.P301L mouse model did not resemble that observed in AD patients. Injection of synthetic or patient-derived tau fibrils in the CA1 region resulted in a more faithful spreading pattern. Atlas-guided volumetric analysis showed a connectome-dependent spreading from the injection site and also revealed hyperphosphorylated tau deposits beyond the direct anatomical connections. In fibril-injected brains, we also detected a persistent subpopulation of rod-like and swollen microglia. Furthermore, we showed that the hyperphosphorylated tau load could be reduced by intracranial co-administration of, and to a lesser extent, by repeated systemic dosing with an antibody targeting the microtubule-binding domain of tau. Thus, the combination of targeted seeding and in toto staging of tau pathology allowed assessing regional vulnerability in a comprehensive manner, and holds potential as a preclinical drug validation tool.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Hyperphosphorylated tau; Light-sheet microscopy; Microglia; Tau; Tau.P301L; Tissue clearing; Whole brain imaging

Mesh:

Substances:

Year:  2019        PMID: 30878534     DOI: 10.1016/j.nbd.2019.03.010

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  9 in total

1.  Pathological and neurophysiological outcomes of seeding human-derived tau pathology in the APP-KI NL-G-F and NL-NL mouse models of Alzheimer's Disease.

Authors:  S Tok; H Maurin; C Delay; D Crauwels; N V Manyakov; W Van Der Elst; D Moechars; W H I M Drinkenburg
Journal:  Acta Neuropathol Commun       Date:  2022-06-23       Impact factor: 7.578

2.  Neurophysiological effects of human-derived pathological tau conformers in the APPKM670/671NL.PS1/L166P amyloid mouse model of Alzheimer's disease.

Authors:  S Tok; H Maurin; C Delay; D Crauwels; N V Manyakov; W Van Der Elst; D Moechars; W H I M Drinkenburg
Journal:  Sci Rep       Date:  2022-05-11       Impact factor: 4.996

3.  An Optimized Mouse Brain Atlas for Automated Mapping and Quantification of Neuronal Activity Using iDISCO+ and Light Sheet Fluorescence Microscopy.

Authors:  Johanna Perens; Casper Gravesen Salinas; Jacob Lercke Skytte; Urmas Roostalu; Anders Bjorholm Dahl; Tim B Dyrby; Franziska Wichern; Pernille Barkholt; Niels Vrang; Jacob Jelsing; Jacob Hecksher-Sørensen
Journal:  Neuroinformatics       Date:  2021-07

4.  Quantitative whole-brain 3D imaging of tyrosine hydroxylase-labeled neuron architecture in the mouse MPTP model of Parkinson's disease.

Authors:  Urmas Roostalu; Casper B G Salinas; Ditte D Thorbek; Jacob L Skytte; Katrine Fabricius; Pernille Barkholt; Linu M John; Vanessa Isabell Jurtz; Lotte Bjerre Knudsen; Jacob Jelsing; Niels Vrang; Henrik H Hansen; Jacob Hecksher-Sørensen
Journal:  Dis Model Mech       Date:  2019-11-22       Impact factor: 5.758

5.  p38 activation occurs mainly in microglia in the P301S Tauopathy mouse model.

Authors:  Juan R Perea; Esther García; Laura Vallés-Saiz; Raquel Cuadros; Félix Hernández; Marta Bolós; Jesús Avila
Journal:  Sci Rep       Date:  2022-02-08       Impact factor: 4.996

6.  Does proteopathic tau propagate trans-synaptically in the brain?

Authors:  Wen Hu; Fei Liu; Cheng-Xin Gong; Khalid Iqbal
Journal:  Mol Neurodegener       Date:  2022-03-16       Impact factor: 14.195

Review 7.  Digital Brain Maps and Virtual Neuroscience: An Emerging Role for Light-Sheet Fluorescence Microscopy in Drug Development.

Authors:  Johanna Perens; Jacob Hecksher-Sørensen
Journal:  Front Neurosci       Date:  2022-04-20       Impact factor: 5.152

8.  Non-invasive imaging of tau-targeted probe uptake by whole brain multi-spectral optoacoustic tomography.

Authors:  Patrick Vagenknecht; Artur Luzgin; Maiko Ono; Bin Ji; Makoto Higuchi; Daniela Noain; Cinzia A Maschio; Jens Sobek; Zhenyue Chen; Uwe Konietzko; Juan A Gerez; Roland Riek; Daniel Razansky; Jan Klohs; Roger M Nitsch; Xose Luis Dean-Ben; Ruiqing Ni
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-02-07       Impact factor: 10.057

9.  P62 accumulates through neuroanatomical circuits in response to tauopathy propagation.

Authors:  François-Xavier Blaudin de Thé; Benjamin Lassus; Ari W Schaler; Stephanie L Fowler; Chris N Goulbourne; Ross Jeggo; Clotilde Mannoury la Cour; Mark J Millan; Karen E Duff
Journal:  Acta Neuropathol Commun       Date:  2021-11-02       Impact factor: 7.801

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.